首页> 外文OA文献 >First Line Androgen Deprivation Therapy Duration Is Associated with the Efficacy of Abiraterone Acetate Treated Metastatic Castration-Resistant Prostate Cancer after Docetaxel

【2h】

First Line Androgen Deprivation Therapy Duration Is Associated with the Efficacy of Abiraterone Acetate Treated Metastatic Castration-Resistant Prostate Cancer after Docetaxel

机译：多西紫杉醇治疗前一线雄激素剥夺治疗持续时间与醋酸阿比特龙治疗转移性去势抵抗前列腺癌的疗效相关

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Jian-Ri Li; Shian-Shiang Wang; Cheng-Kuang Yang; Chuan-Su Chen; Hao-Chung Ho; Kun-Yuan Chiu; Chi-Feng Hung; Chen-Li Cheng; Chi-Rei Yang; Cheng-Che Chen; Shu-Chi Wang; Chia-Yen Lin; Yen-Chuan Ou;
展开▼
作者单位

展开▼
年度 2017
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Effectiveness of Deferred Combined Androgen Blockade Therapy Predicts Efficacy in Abiraterone Acetate Treated Metastatic Castration-Resistant Prostate Cancer Patients after Docetaxel [J] . Jian-Ri Li, Kun-Yuan Chiu, Shian-Shiang Wang, Frontiers in Pharmacology . 2017,第4期

机译：延迟联合雄激素阻断疗法的有效性预测多西他赛治疗后醋酸阿比特龙治疗转移性去势抵抗的前列腺癌患者的疗效。
2. Abiraterone acetate/androgen deprivation therapy combination versus docetaxel/androgen deprivation therapy combination in advanced hormone-sensitive prostate cancer: a network meta-analysis on safety and efficacy [J] . Kassem Loay, Shohdy Kyrillus S., Abdel-Rahman Omar Current medical research and opinion . 2018,第5期

机译：AbiraTerone醋酸盐/雄激素剥夺治疗组合与多西紫杉醇/雄激素剥夺治疗组合在晚期激素敏感前列腺癌中：网络元分析安全性和疗效
3. NUMBER NEEDED TO TREAT AND COST PER CLINICALLY MEANINGFUL OUTCOME OF ENZALUTAMIDE AND ABIRATERONE ACETATE FOR THE TREATMENT OF METASTATIC CASTRATION-RESISTANT PROSTATE CANCER THAT FAILED ANDROGEN DEPRIVATION THERAPY IN BRAZIL [J] . Sasse A. P., Lopes G., Teich V, Value in health: the journal of the International Society for Pharmacoeconomics and Outcomes Research . 2016,第7期

机译：根据临床意义评估恩扎鲁米特和醋酸阿比特雷酮用于治疗转移性抗前列腺癌的前列腺癌的治疗和费用的数字
4. Serum levels of sex hormones before and after androgen deprivation therapy in Japanese prostate cancer patients [C] . A. Komiya, K. Ichimatsu, A. Morii, International Congress of Andrology . 2009

机译：日本前列腺癌患者中雄激素剥夺治疗前后的性激素血清水平
5. Muscle Cross-Sectional Area Is Improved and Physical Funciton Is Maintained After Home-Based Exercise in Men with Metastatic Castration-Resistant Prostate Cancer Undergoing Androgen Deprivation Therapy [D] . Alzer, Mohamdod Saber. 2020

机译：改善肌横截面积，并且在具有转移阉割的前列腺癌接受雄激素剥夺治疗的男性中的男性锻炼之后，将物理静脉凝集维持
6. First Line Androgen Deprivation Therapy Duration Is Associated with the Efficacy of Abiraterone Acetate Treated Metastatic Castration-Resistant Prostate Cancer after Docetaxel [O] . Jian-Ri Li, Shian-Shiang Wang, Cheng-Kuang Yang, 2017

机译：一线雄激素剥夺治疗的持续时间与多西他赛治疗后醋酸阿比特龙治疗转移性去势抵抗前列腺癌的疗效有关
7. Effectiveness of Deferred Combined Androgen Blockade Therapy Predicts Efficacy in Abiraterone Acetate Treated Metastatic Castration-Resistant Prostate Cancer Patients after Docetaxel [O] . Jian-Ri Li, Kun-Yuan Chiu, Shian-Shiang Wang, 2017

机译：延迟联合雄激素阻断疗法的有效性预测多西紫杉醇治疗转移性去势抵抗前列腺癌患者多西紫杉醇治疗后的疗效

First Line Androgen Deprivation Therapy Duration Is Associated with the Efficacy of Abiraterone Acetate Treated Metastatic Castration-Resistant Prostate Cancer after Docetaxel

著录项

引文网络

相似文献

相关主题

期刊订阅